Bio-Rad Extends Range of Anti-Idiotypic Antibodies and Anti-Fc Mutation Antibodies for Bioanalysis and Drug Monitoring
Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications
Bio-Rad Laboratories, Inc. (NYSE:...
























